Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2010-4-7
pubmed:abstractText
Cyclosporin A (CSA), an immunosuppressive agent, is highly efficacious in patients with refractory ulcerative colitis (UC). We retrospectively investigated patients with refractory UC treated with CSA therapy to elucidate the efficacy and the prognostic factors.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1440-1746
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
25
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
494-8
pubmed:meshHeading
pubmed-meshheading:20370728-Adolescent, pubmed-meshheading:20370728-Adult, pubmed-meshheading:20370728-Azathioprine, pubmed-meshheading:20370728-Colectomy, pubmed-meshheading:20370728-Colitis, Ulcerative, pubmed-meshheading:20370728-Cyclosporine, pubmed-meshheading:20370728-Dose-Response Relationship, Drug, pubmed-meshheading:20370728-Drug Resistance, pubmed-meshheading:20370728-Drug Therapy, Combination, pubmed-meshheading:20370728-Female, pubmed-meshheading:20370728-Humans, pubmed-meshheading:20370728-Immunosuppressive Agents, pubmed-meshheading:20370728-Male, pubmed-meshheading:20370728-Middle Aged, pubmed-meshheading:20370728-Recurrence, pubmed-meshheading:20370728-Remission Induction, pubmed-meshheading:20370728-Retrospective Studies, pubmed-meshheading:20370728-Risk Factors, pubmed-meshheading:20370728-Severity of Illness Index, pubmed-meshheading:20370728-Survival Rate, pubmed-meshheading:20370728-Treatment Outcome
pubmed:year
2010
pubmed:articleTitle
Factors affecting the efficacy of cyclosporin A therapy for refractory ulcerative colitis.
pubmed:affiliation
Division of Gastroenterology, Department of Internal Medicine, Shiga University of Medical Science, Japan. sb@belle.shiga-med.ac.jp
pubmed:publicationType
Journal Article